Skip to content
10-Q

Quarterly Report

Janux Therapeutics, Inc. JANX

0001193125-25-269799

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 60.15M sh
Shares Diluted Q3 2025 · Sep 30, 2025 62.02M sh
Shares Diluted Q3 2025 · Sep 30, 2025 61.91M sh
Shares Diluted Q3 2025 · Sep 30, 2024 54.63M sh
Shares Diluted Q3 2025 · Sep 30, 2024 52.72M sh
Capex Q3 2025 · Sep 30, 2025 $937K
Capex Q3 2025 · Sep 30, 2024 $317K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$53.69M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$27.09M
Short Term Investments Q3 2025 · Sep 30, 2025 $940.6M
Short Term Investments Q3 2025 · Dec 31, 2024 $594.57M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $48.39M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $430.61M
Stockholders Equity Q3 2025 · Sep 30, 2025 $976.56M
Stockholders Equity Q3 2025 · Jun 30, 2025 $990.52M
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.02B
Stockholders Equity Q3 2025 · Sep 30, 2024 $656.1M
Stockholders Equity Q3 2025 · Jun 30, 2024 $657.68M
Stockholders Equity Q3 2025 · Dec 31, 2023 $344.35M
Current Liabilities Q3 2025 · Sep 30, 2025 $27.83M
Current Liabilities Q3 2025 · Dec 31, 2024 $17.46M
Total Liabilities Q3 2025 · Sep 30, 2025 $48.21M
Total Liabilities Q3 2025 · Dec 31, 2024 $38.74M
Current Assets Q3 2025 · Sep 30, 2025 $998.09M
Current Assets Q3 2025 · Dec 31, 2024 $1.03B
Total Assets Q3 2025 · Sep 30, 2025 $1.02B
Total Assets Q3 2025 · Dec 31, 2024 $1.06B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.39
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.51
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.93
Eps Basic Q3 2025 · Sep 30, 2025 −$0.39
Eps Basic Q3 2025 · Sep 30, 2025 −$1.32
Eps Basic Q3 2025 · Sep 30, 2024 −$0.51
Eps Basic Q3 2025 · Sep 30, 2024 −$0.93
Sga Expense Q3 2025 · Sep 30, 2025 $10.62M
Sga Expense Q3 2025 · Sep 30, 2025 $30.92M
Sga Expense Q3 2025 · Sep 30, 2024 $17.67M
Sga Expense Q3 2025 · Sep 30, 2024 $32.83M
Rd Expense Q3 2025 · Sep 30, 2025 $34.63M
Rd Expense Q3 2025 · Sep 30, 2025 $94.35M
Rd Expense Q3 2025 · Sep 30, 2024 $18.61M
Rd Expense Q3 2025 · Sep 30, 2024 $47.58M
Net Income Q3 2025 · Sep 30, 2025 −$24.31M
Net Income Q3 2025 · Sep 30, 2025 −$81.68M
Net Income Q3 2025 · Sep 30, 2024 −$28.06M
Net Income Q3 2025 · Sep 30, 2024 −$48.78M
Operating Income Q3 2025 · Sep 30, 2025 −$35.25M
Operating Income Q3 2025 · Sep 30, 2025 −$115.27M
Operating Income Q3 2025 · Sep 30, 2024 −$35.84M
Operating Income Q3 2025 · Sep 30, 2024 −$69.83M
Revenue Q3 2025 · Sep 30, 2025 $10M
Revenue Q3 2025 · Sep 30, 2025 $10M
Revenue Q3 2025 · Sep 30, 2024 $439K
Revenue Q3 2025 · Sep 30, 2024 $10.59M